NeurAxis, Inc. Share Price & Technical Analysis
NRXS · $7.38 (-0.67%)
Healthcare / Biotechnology
$7.38
-0.67%
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional d…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 4 years shown)
-1% return in May, 9% avg return in past 3 year May month.
66% return in 2026, 21% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | 43% | 28% | 1% | -1% | – | – | – | – | – | – | – | 66% |
| 25 | 9% | -15% | 0% | 10% | 17% | -11% | 8% | -4% | 24% | -13% | 4% | 67% | 95% |
| 24 | -7% | 46% | -9% | 0% | 0% | -12% | 14% | -3% | -3% | -10% | 11% | -23% | 3% |
| 23 | – | – | – | – | – | – | – | -32% | -12% | -44% | 68% | -16% | -35% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Uptrend · Neutral
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$91.35M
P/E ratio
—
52W high
$9.33
52W low
$2.20
Volume
93,435
Beta
1.48
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is NeurAxis, Inc. share price today?
- NeurAxis, Inc. (NRXS) last traded around $7.38 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NRXS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NRXS. Download the app for real-time alerts.
- How can I analyze NeurAxis, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.